Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7415231

CCCCOc1ccc(S(=O)(=O)N[C@@H](Cc2ccc(OCCCONC(=N)N)cc2)C(=O)O)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 11/20 0.52
ITGA2B P08514 11/20 0.52
MMP3 P08254 1/20 0.51
MMP13 P45452 1/20 0.51
KCNA5 P22460 1/20 0.51
F2 P00734 2/20 0.48
TMPRSS6 Q8IU80 2/20 0.48
MMP2 P08253 1/20 0.48
MMP9 P14780 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
ITGAV P06756 1/20 0.47
CHRM2 P08172 1/20 0.47
SLC6A4 P31645 1/20 0.47
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.45
TDP1 Q9NUW8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7412846 0.97 ITGB3 (0.49) ITGB3ITGA2BMMP3MMP13KCNA5
Trifluoroacetic Acid SCHEMBL7413576 0.96 ITGB3 (0.49) ITGB3ITGA2BMMP3MMP13KCNA5
Trifluoroacetic Acid SCHEMBL7418516 0.96 ITGB3 (0.49) ITGB3ITGA2BMMP3MMP13KCNA5
SCHEMBL7420817 0.95 ITGB3 (0.56) ITGB3ITGA2BMMP3MMP13KCNA5
Trifluoroacetic Acid SCHEMBL7694788 0.94 MMP2 (0.56) ITGB3ITGA2BMMP3MMP13KCNA5
Trifluoroacetic Acid SCHEMBL7416567 0.94 ITGB3 (0.55) ITGB3ITGA2BMMP3MMP13KCNA5
Trifluoroacetic Acid SCHEMBL7699204 0.93 ITGB3 (0.51) ITGB3ITGA2BF2TMPRSS6MMP2
Trifluoroacetic Acid SCHEMBL7417586 0.93 ITGB3 (0.59) ITGB3ITGA2BF2TMPRSS6MMP2
Trifluoroacetic Acid SCHEMBL7418011 0.92 ALDH1A1 (0.57) ITGB3ITGA2BMMP3MMP13KCNA5
Trifluoroacetic Acid SCHEMBL7695353 0.92 ITGB3 (0.50) ITGB3ITGA2BF2TMPRSS6MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6344484-B1 TREATMENT OF TUMOR GROWTH, METASTASIS, OSTEOPOROSIS, RESTENOSIS, INFLAMMATION, MACULAR DEGENERATION, DIABETIC RETINOPATHY, AND RHEUMATOID ARTHRITIS 3-DIMENSIONAL PHARMACEUTICALS, INC. 2002-02-05 US disclosed
EP-1159262-A1 TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2001-12-05 EP disclosed
WO-2000047552-A1 TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2000-08-17 WO disclosed